Harvard Business Review

MARCH 11, 2014

Isn’t it better to hasten Joseph Schumpeter’s process of creative destruction and move capital and employment from inefficient dinosaurs to more vibrant and agile upstarts? I give them three reasons. First, timing matters. Second, the world of start-ups is narrowly focused.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. Through PEP we have created a smarter, more agile, and more responsive organization," says Pierce.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22